Astro-Med, Inc. (ALOT) - 10-K Summary
Business Context and Reporting Period
Company: Astro-Med, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: January 31, 2002
Business Overview: A diversified enterprise organized into three product groups: Test & Measurement (T&M), QuickLabel Systems (QLS), and Grass-Telefactor (G-T). The company designs, manufactures, and sells data acquisition instruments, digital label printers, and clinical neurophysiology equipment. Approximately 28% of sales are international.
Key Financial Metrics
| Metric (in thousands) | Fiscal 2002 | Fiscal 2001 |
|---|---|---|
| Net Sales | $49,391 | $51,688 |
| Gross Profit | $19,106 | $20,792 |
| Gross Margin | 38.7% | 40.2% |
| Operating Income (Loss) | $(728) | $81 |
| Net Income (Loss) | $(233) | $302 |
| Diluted EPS | $(0.05) | $0.07 |
| Working Capital | $21,455 | $21,908 |
| Cash & Equivalents | $2,570 | $806 |
| Long-Term Debt | $0 | $25 |
| Operating Cash Flow | $1,281 | $(2,592) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 4.7% to $49.4 million, driven by a 6.6% drop in domestic sales. International sales remained relatively flat.
- Profitability Reversal: The company reported a net loss of $0.2 million in 2002, compared to a net income of $0.3 million in 2001. This was primarily due to lower sales volume and reduced gross margins.
- Margin Compression: Gross profit margin declined to 38.7% from 40.2%, attributed to lower margins on new T&M products and QLS products.
- Expense Reduction: SG&A expenses decreased 2.4% and R&D expenses decreased 14.2% (to $3.7 million), largely due to workforce reductions and temporary layoffs.
- Cash Flow Improvement: Operating cash flow turned positive at $1.3 million, reversing a $2.6 million outflow in 2001, due to lower receivables and inventory balances.
Segment Performance and Outlook
- Test & Measurement (T&M): Sales fell 12.9% to $12.1 million with margins dropping to 5.6%. Delays in the new Dash 18 recorder and a 34% drop in international sales were key factors.
- QuickLabel Systems (QLS): Sales grew 5.0% to $20.9 million, driven by a 17.8% increase in international sales. However, segment margins declined to 4.1% due to lower margins on international sales.
- Grass-Telefactor (G-T): Sales decreased 8.4% to $16.4 million due to delays in new PSG software and sales force turnover. Despite lower sales, operating margins improved to 5.0% from 3.0% due to cost reductions.
- Outlook & Risks: Management anticipates financing future needs through internal funds and a $3.5 million bank line of credit. Key risks include declining demand in defense/aerospace, competition in specialty printing, and foreign currency exchange rate fluctuations.
- Unusual Items: Other income included a $165,000 gain on litigation settlement and $68,000 in NIH grant income.
Investor Verification Checklist
- Product Launch Delays: Verify the timeline and market acceptance for the delayed Dash 18 recorder (T&M) and new PSG software (G-T).
- Margin Sustainability: Assess whether the decline in gross margins (38.7%) is a temporary result of new product introductions or a structural shift in pricing power.
- International Exposure: Review the impact of foreign currency fluctuations, as 28% of sales are international and the company holds $2.9 million in foreign assets.
- Acquisition Contingencies: Confirm the status of the earn-out provision for the Telefactor acquisition (potential additional payment of up to $3 million if sales targets are met over 72 months).
- Stock Buyback Authorization: Note that the Board has authorization to purchase an additional 290,000 shares, though no repurchases occurred in fiscal 2002.